Biotie Therapies Corp. (“Biotie” or the “Company”) has announced on 19 January 2016 that the Company and Acorda Therapeutics, Inc. (“Acorda”) have entered into a combination agreement whereby Acorda will make a public tender offer to purchase all of the issued and outstanding shares, American Depositary Shares, stock options, share units and warrants in Biotie that are not owned by Biotie or any of its subsidiaries (the “Tender Offer”).
Biotie has been informed by Acorda that the Finnish Financial Supervisory Authority has today approved the tender offer document relating to the Tender Offer and that the acceptance period under the Tender Offer will commence on 11 March 2016 at 9:30 am Finnish time and preliminarily expire on 8 April 2016 at 4 pm Finnish time.
